✦ LIBER ✦

First-line sunitinib plus FOLFIRI in Japanese patients with unresectable/metastatic colorectal cancer: A phase II study

✍ Scribed by Yasushi Tsuji; Taroh Satoh; Akihito Tsuji; Kei Muro; Motoki Yoshida; Tomohiro Nishina; Michitaka Nagase; Yoshito Komatsu; Takeshi Kato; Yoshinori Miyata; Naoko Mizutani; Satoshi Hashigaki; Maria Jose Lechuga; Tadamichi Denda

Book ID: 114703294
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 158 KB
Volume: 103
Category: Article
ISSN: 1347-9032
DOI: 10.1111/j.1349-7006.2012.02320.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FOLFIRI plus bevacizumab as a first-line

FOLFIRI plus bevacizumab as a first-line treatment for Japanese patients with metastatic colorectal cancer: a JACCRO CC-03 multicenter phase II study

✍ Kochi, Mitsugu; Akiyama, Yuji; Aoki, Tatsuya; Hagiwara, Ken; Takahashi, Takao; H 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 453 KB

6063 Phase I study of first-line sunitin

6063 Phase I study of first-line sunitinib (SU) plus modified FOLFOX6 (mFOLFOX6) in Japanese patients (pts) with metastatic colorectal cancer (mCRC)

✍ Hamaguchi, T.; Yoshino, T.; Ohtsu, A.; Yamazaki, K.; Shimada, Y.; Kato, K.; Yasu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Phase II clinical trial of second-line F

Phase II clinical trial of second-line FOLFIRI plus bevacizumab for patients with metastatic colorectal cancer: AVASIRI trial

✍ Horita, Yosuke; Yamada, Yasuhide; Kato, Ken; Hirashima, Yoshinori; Akiyoshi, Kou 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 334 KB

Phase I Study of Gefitinib plus FOLFIRI

Phase I Study of Gefitinib plus FOLFIRI in Previously Untreated Patients with Metastatic Colorectal Cancer

✍ Brian M. Wolpin; Jeffrey W. Clark; Jeffrey A. Meyerhardt; Craig C. Earle; David 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 150 KB

Simvastatin plus irinotecan, 5-fluoroura

Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study

✍ Jeeyun Lee; Kyung Hae Jung; Young Suk Park; Joong Bae Ahn; Sang Jun Shin; Seock- 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 284 KB

FOLFIRI plus cetuximab versus FOLFIRI pl

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial

✍ Heinemann, Volker; von Weikersthal, Ludwig Fischer; Decker, Thomas; Kiani, Alexa 📂 Article 📅 2014 🏛 Lancet Publishing Group 🌐 English ⚖ 289 KB